After ex-CEO Pourhassan’s indictment, what’s left of CytoDyn?


The Department of Justice unsealed a federal indictment on Tuesday charging Nader Pourhassan and an associate with defrauding investors.

Previous Little-known 'liquid biopsy' company looks to roll out cancer test in hotly contested market
Next Bob's Red Mill CEO Trey Winthrop on ESOPs, innovation and landing his dream job